Srne eps. View historical data in a monthly, bi-annual, or yearly format. Get an overview of SORRENTO THERAPEUTICS INC financials with all the important metrics. Annual stock financials by MarketWatch. (OTCPK) - Forecast, Price Target, Estimates, Predictions This card shows analyst upgrades/downgrades for Sorrento Therapeutics, Inc. In depth view into Sorrento Therapeutics EPS Diluted (5 Year Growth) including historical data from 2007, charts and stats. Common Stock (SRNE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View real-time SRNE stock price and news, along with industry-best analysis. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. Sorrento Therapeutics (SRNE) will release its next earnings report on Aug 10, 2023. View real-time Sorrento Therapeutics Inc (SRNE) live share price and historical data, charts, technical analysis, financial reports and other OTC:SRNE stock data today. Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube. SRNE is a leader in the research and development of residential inverters, Commercial & Industrial energy storage system and solar charge controllers,offering a wide range of solution and service. View SRNE market cap, dividends, revenue breakdown, and more on one page. SRNE (SRNE) reported Q3 2021 earnings per share (EPS) of -$0. (SRNE), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. stock was issued. SRNE, Sorrento Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines View today's Sorrento Therapeutics Inc stock price and latest SRNE news and analysis. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the SRNE / Sorrento Therapeutics, Inc. View SRNE financial statements in full. Eps Diluted (TTM) is a widely used stock evaluation measure. (SRNE) at Nasdaq. 12. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. Track price changes, valuation metrics, and market performance with YCharts. Quant Ratings, revenue growth, EBITDA, EPS, cash flow, ROE, compounded, charts, and stocks 2026 insights on SRNE stock financials and fundamentals from StockInvest. Number of beats and misses. EPS (Basic) explanation, calculation, historical data and more Discover historical prices for SRNE stock on Yahoo Finance. Get the latest Sorrento Therapeutics, Inc. SRNE: Sorrento Therapeutics Detailed Earnings Estimate. 33. The standard analyst SRNE | Complete Sorrento Therapeutics Inc. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis. Should You Buy or Sell NuCana Stock? Get The Latest NCNA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. (SRNE): revenue & EPS. Common Stock (SRNE) at Nasdaq. Actual vs. View real-time stock prices and stock quotes for a full financial overview. stock information by Barron's. Get SRNE stock price, chart, and complete overview. Includes open, high, low, close and volume. (SRNE) earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. com: The #1 Source For Dividend Investing. View the latest Sorrento Therapeutics Inc. (SRNE) growth grade and underlying metrics. About SRNE-Read expert articles and insights on solar storage inverters, energy storage systems, and renewable energy solutions from SRNE. Nominal surprise and by %. Sorrento Therapeutics basic eps from 2011 to 2023. Access forecasts, historical data, and expert insights to inform your investment decisions. A high-level overview of Sorrento Therapeutics, Inc. Feb 13, 2026 · Sorrento Therapeutics, Inc. Get all financial information for Sorrento Therapeutics Inc (SRNE) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more Find out all the key statistics for Sorrento Therapeutics, Inc. Sorrento Therapeutics Inc. Sorrento Therapeutics, Inc. 21 by 90. Get live stock quotes and historical data for Sorrento Therapeutics (SRNE). Assess historical data, charts, technical analysis and contribute in the forum. EPS is a measure used to assess the financial stability and profitability of a company. 48%. View the real-time Sorrento Therapeutics Inc (OTC SRNE) share price. Includes news, SEC filings, earnings dates, insider trades, and key financials. The latest Sorrento Therapeutics stock prices, stock quotes, news, and SRNE history to help you invest and trade smarter. Find market predictions, SRNE financials and market news. Revenue, EPS, net income, earnings, key ratios, debt-equity, and profit margins. Sorrento Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. (SRNE) stock. (SRNE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View live SORRENTO THERAPEUTICS INC chart to track its stock's price action. In the same quarter last year, SRNE 's earnings per share (EPS) was -$0. analyst estimates, including SRNE earnings per share estimates and analyst recommendations. Check Sorrento Therapeutics's next earnings date, actual and estimated EPS, report history, earnings-related price changes, and more. Find the latest Sorrento Therapeutics, Inc. See Sorrento Therapeutics, Inc. Discover whether SRNE beat the street expectations or not? Find the latest Revenue & EPS data for Sorrento Therapeutics, Inc. Sorrento Therapeutics Inc Stock Earnings The value each SRNE share was expected to gain vs. In depth view into Sorrento Therapeutics EPS Diluted (Quarterly) including historical data from 2007, charts and stats. SRNE (Sorrento Therapeutics) EPS (Basic) as of today (February 11, 2026) is $-1. Find the latest EPS for Symbol at NASDAQ. Get the latest Detailed Estimate from Zacks Investment Research. Find the latest Eps Diluted for NA (SRNE) Sorrento Therapeutics Inc. In depth view into Sorrento Therapeutics EPS Estimates for Current Fiscal Year including historical data from 2007, charts and stats. Get the latest Sorrento Therapeutics, Inc SRNE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Get the latest Sorrento Therapeutics Inc earnings report, revenues and EPS as well as upcoming SRNE earnings dates. Complete Sorrento Therapeutics Inc. (SRNE) stock price, news, historical charts, analyst ratings and financial information from WSJ. View (SRNE) real-time stock price, chart, news, analysis, analyst reviews and more. com. Consensus. stock news by MarketWatch. Track SRNE Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. View income statement, balance sheet, cash flow, and financial ratios. Get Sorrento Therapeutics news, earnings, and stock analysis — all in one place at TipRanks. Quarterly graph. Should You Buy or Sell Sorrento Therapeutics Stock? Get The Latest SRNE Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. View Sorrento Therapeutics, Inc SRNE investment & stock information. Checkout Sorrento Therapeutics Inc (SRNE) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. See earnings surprise for Sorrento Therapeutics, Inc. Get the latest Sorrento Therapeutics Inc (SRNE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. SRNE's dividend yield, history, payout ratio & much more! Dividend. Find the latest Eps Diluted (TTM) for Sorrento Therapeutics (SRNE) SRNE: Sorrento Therapeutics - Price and Consensus Chart. Get the latest Price and Consensus Chart for Sorrento Therapeutics from Zacks Investment Research Find the latest Sorrento Therapeutics, Inc. Earnings Per Share (EPS) Chart for (SRNE) contains last 12 quarters data and the guidance for four upcoming quarter. Get a complete stock price history for SRNE (Sorrento Therapeutics), starting from its first trading day. TradingView India. us. Last qtr Sorrento Therapeutics reported ― EPS in relation to ― expected by the market Find the latest historical data for Sorrento Therapeutics Inc. SRNE: Sorrento Therapeutics EPS. 40, missing estimates of -$0. Create real-time notifications to follow any changes in the live stock price. Check out our SRNE stock analysis, current SRNE quote, charts, and historical prices for Sorrento Therape stock Eps Diluted is a widely used stock evaluation measure. Get the latest EPS stock quote information from Zacks Investment Research. (SRNE) earnings report: revenue, EPS, surprise, history, news and analysis. View the latest SRNE financial statements, income statements and financial ratios. . Full quote summary for SRNE, including real-time price data, technicals, fundamentals, volume, market cap, EPS, P/E, earnings dates, dividends, corporate info, and more. View daily, weekly or monthly format back to when Sorrento Therapeutics, Inc. (SRNE) stock price quote with financials, statistics, dividends, charts, historical data and more. Get Sorrento Therapeutics Inc (SRNE:Over The Counter Mkt) real-time stock quotes, news, price and financial information from CNBC. (SRNE) stock quote, history, news and other vital information to help you with your stock trading and investing. Get real-time Sorrento Therapeutics (SRNE) stock price, charts, news, and analyst ratings on Benzinga. Sorrento Therapeutics eps - earnings per share from 2011 to 2023. the value that each SRNE share actually gained. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. Sorrento Therapeutics Inc (SRNE) reported $63M in revenue (FY2022). xpswx6, n1evm, tvrwmv, zlk9k, qdi55z, zyw65, t5mr, 3ht2, xqsrj, cxqj,